Recruiting Hereditary Angioedema Studies in Wheaton
A Study of Navenibart in Participants With Hereditary Angioedema
This is a Phase 3 multicenter, randomized, double-blind, placebo-controlled clinical trial evaluating the safety and efficacy of subcutaneous administration of navenibart in adult and adolescent parti...
Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With HAE Type I or II
KVD900-303 is an open-label, multicenter clinical trial in patients aged 2 to 11 years old with HAE Type I or II....
About Hereditary Angioedema Clinical Trials in Wheaton
Hereditary angioedema (HAE) is a rare genetic condition causing recurrent episodes of severe swelling in various body parts. It is caused by deficiency or dysfunction of C1 inhibitor protein. Treatment includes on-demand therapy for attacks and prophylactic medications to prevent episodes.
There are currently 2 hereditary angioedema clinical trials recruiting participants in Wheaton, MARYLAND. These studies are seeking a combined 193 participants. Research is being sponsored by Astria Therapeutics, Inc., KalVista Pharmaceuticals, Ltd.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Hereditary Angioedema Clinical Trials in Wheaton — FAQ
Are there hereditary angioedema clinical trials in Wheaton?
Yes, there are 2 hereditary angioedema clinical trials currently recruiting in Wheaton, MARYLAND. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Wheaton?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Wheaton research site will contact you about next steps.
Are clinical trials in Wheaton free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Wheaton studies also compensate for your time and travel.
What hereditary angioedema treatments are being tested?
The 2 active trials in Wheaton are testing new therapies including novel drugs, biologics, and treatment approaches for hereditary angioedema.
Data updated March 2, 2026 from ClinicalTrials.gov